Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

January 19, 2021

Conditions

Amyotrophic Lateral SclerosisALS

Interventions

DRUG

Fixed dose combination Ciprofloxacin/Celecoxib

Fixed dose Ciprofloxacin and Celecoxib capsule to be taken thrice daily, total dose 909mg/day

Trial Locations (1)

Sourasky Medical Center, Tel Aviv